SE432193B - Forfarande for framstellning av lekemedelspreparat med en mangfald underenheter och med kontrollerad frigorning av aktiv substans - Google Patents

Forfarande for framstellning av lekemedelspreparat med en mangfald underenheter och med kontrollerad frigorning av aktiv substans

Info

Publication number
SE432193B
SE432193B SE7803527A SE7803527A SE432193B SE 432193 B SE432193 B SE 432193B SE 7803527 A SE7803527 A SE 7803527A SE 7803527 A SE7803527 A SE 7803527A SE 432193 B SE432193 B SE 432193B
Authority
SE
Sweden
Prior art keywords
density
subunits
active substance
preparation
controlled release
Prior art date
Application number
SE7803527A
Other languages
English (en)
Swedish (sv)
Other versions
SE7803527L (sv
Inventor
H Bechgaard
A M Pedersen
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Publication of SE7803527L publication Critical patent/SE7803527L/xx
Publication of SE432193B publication Critical patent/SE432193B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7803527A 1977-03-30 1978-03-29 Forfarande for framstellning av lekemedelspreparat med en mangfald underenheter och med kontrollerad frigorning av aktiv substans SE432193B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13296/77A GB1576376A (en) 1977-03-30 1977-03-30 Multiple-unit drug dose

Publications (2)

Publication Number Publication Date
SE7803527L SE7803527L (sv) 1978-10-01
SE432193B true SE432193B (sv) 1984-03-26

Family

ID=10020381

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803527A SE432193B (sv) 1977-03-30 1978-03-29 Forfarande for framstellning av lekemedelspreparat med en mangfald underenheter och med kontrollerad frigorning av aktiv substans

Country Status (12)

Country Link
US (1) US4193985A (de)
BE (1) BE865451A (de)
CH (1) CH629956A5 (de)
DE (1) DE2813480C2 (de)
DK (1) DK147591C (de)
FI (1) FI69564C (de)
FR (1) FR2395026A1 (de)
GB (1) GB1576376A (de)
LU (1) LU79333A1 (de)
NL (1) NL189747C (de)
NO (1) NO149376C (de)
SE (1) SE432193B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (de) * 1980-03-20 1982-03-11
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
EP0092993B1 (de) * 1982-04-23 1989-03-01 A/S Alfred Benzon Zusammensetzung zur Untersuchung von Alimentärfunktionen
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3586600T2 (de) 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
DE3431861A1 (de) * 1984-08-30 1986-03-13 Troponwerke GmbH & Co KG, 5000 Köln Pellet-zubereitung
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629620A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4976949A (en) * 1985-10-25 1990-12-11 The University Of Michigan Controlled release dosage form
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
NZ234227A (en) * 1989-06-30 1991-08-27 Smithkline Beecham Corp Delayed release dosage form
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US6558708B1 (en) 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
EP0827402A2 (de) * 1995-05-17 1998-03-11 Cedars-Sinai Medical Center Fettsäure enthaltende zusammensetzungen zur verbesserung der verdauung und absorption des dünndarms
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
EP1245227A1 (de) * 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CN104302278B (zh) 2012-03-29 2018-08-21 塞拉拜姆有限责任公司 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂
WO2014152338A1 (en) 2013-03-14 2014-09-25 Kabadi Mohan Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP3797818B1 (de) 2018-05-23 2023-01-18 Shanghai WD Pharmaceutical Co., Ltd System zur verzögerten freisetzung eines wirkstoffes und verfahren zu seiner herstellung
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN113975413A (zh) * 2021-11-10 2022-01-28 博迈医疗科技(常州)有限公司 一种胃肠动力标记物及其制备方法、胃肠动力标记物胶囊

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801203A (en) * 1951-03-22 1957-07-30 Byk Gulden Lomberg Chem Fab X-ray method of digestive enzyme diagnosis using protected core of contrast agent
BE562124A (de) * 1956-11-05
US3017329A (en) * 1957-08-15 1962-01-16 Dow Chemical Co Method of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
DK106457C (da) * 1962-01-23 1967-02-06 Ernst Helmer Hagstam Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling.
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
JPS4427839B1 (de) * 1966-04-18 1969-11-18
US3592185A (en) * 1967-04-18 1971-07-13 Yeda Res & Dev Ferromagnetic contrast media and method of use
US3608061A (en) * 1968-08-21 1971-09-21 Edmund F Mcnally Radiopaque esophageal marshmallow bolus
JPS4824246B1 (de) * 1969-03-20 1973-07-19
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
AU3784072A (en) * 1971-01-20 1973-07-19 Richter Gedeon Vegyeszet A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity
FR2183546B1 (de) * 1972-05-10 1975-06-20 Servier Lab
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations

Also Published As

Publication number Publication date
NL7803309A (nl) 1978-10-03
US4193985A (en) 1980-03-18
DK147591B (da) 1984-10-15
LU79333A1 (fr) 1978-07-13
NL189747C (nl) 1993-07-16
GB1576376A (en) 1980-10-08
FI69564B (fi) 1985-11-29
NO149376B (no) 1984-01-02
FR2395026B1 (de) 1981-07-24
NO149376C (no) 1984-04-11
DE2813480A1 (de) 1978-10-05
NO781079L (no) 1978-10-03
BE865451A (fr) 1978-07-17
DK137878A (da) 1978-10-01
FI69564C (fi) 1986-03-10
CH629956A5 (fr) 1982-05-28
FI780955A (fi) 1978-10-01
SE7803527L (sv) 1978-10-01
FR2395026A1 (fr) 1979-01-19
DK147591C (da) 1985-07-15
DE2813480C2 (de) 1986-09-25

Similar Documents

Publication Publication Date Title
SE432193B (sv) Forfarande for framstellning av lekemedelspreparat med en mangfald underenheter och med kontrollerad frigorning av aktiv substans
FI97686C (fi) Menetelmä helmien valmistamiseksi tarkoituksena tuottaa hallitusti vapauttavia tuotteita
US4587118A (en) Dry sustained release theophylline oral formulation
EP0013262B1 (de) Ein Herzglykosid mit einem polymeren Überzug enthaltendes pharmazeutisches Präparat und Verfahren zu dessen Herstellung
KR880002673B1 (ko) 진통 캡슐제와 그 제조방법
TW420618B (en) Controlled release-initiation and controlled release-rate pharmaceutical composition
TWI239838B (en) Fluoxetine enteric pellets
SE455836B (sv) Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JPS63196511A (ja) 膨潤しうるペレット
FR2604090A1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
DK151608B (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
WO2005079764A1 (en) Compositions and methods for timed release of water-soluble nutritional supplements
JPH07501343A (ja) 経口用１α−ヒドロキシプレビタミンＤ
CN106511260B (zh) 一种盐酸小檗碱口服微丸干凝胶及其制备方法和应用
CN107205950A (zh) 金刚烷胺组合物的施用方法
EP0083372B1 (de) Theophyllin mit verlängerter abgabe
AU2008318270A1 (en) Improved tablet coating
US4229428A (en) Galenical form of administration of betahistine and its derivatives
RU98111765A (ru) Фармацевтическая композиция для орального введения с модифицированным высвобождением, содержащая 5-аск, и способ лечения кишечных заболеваний
CN108175849B (zh) 聚普瑞锌口服制剂及在制备溃疡性结肠炎药物中的应用
CN103800291A (zh) 一种对氨基水杨酸钠肠溶微丸制剂
NO774400L (no) Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger
CN101069688A (zh) 含有茶碱类药物和维生素k的药物组合物
CN102973533A (zh) 法莫替丁胃漂浮型微丸片的制备
CN116327740A (zh) 一种乳铁蛋白贴剂及其在制备用于儿童反复呼吸道感染治疗药物中的用途

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7803527-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7803527-6

Format of ref document f/p: F